Alethia Young
CIK 1918147 · Chief Financial Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.36M
Companies
4
Total Filings
27
Lifetime Open-Market Net
-$542.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Director | 17,798 | $24.38 | $433.9K | $0 | 4 | 2026-06-12 |
| BCYC | Chief Financial Officer | 91,415 | $4.12 | $376.6K | -$77.4K | 7 | 2026-01-06 |
| PTCT | Director | 21,067 | $73.70 | $1.55M | -$465.0K | 6 | 2026-01-06 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | Chief Financial Officer | — | $22.26 | — | $0 | 2 | 2023-02-23 |
Recent Filings · Page 3 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-08 | PTCT | Mixed | — | -$140.1K | EDGAR |
| 2023-09-06 | PTCT | Notice (144) | −11,666 | -$465.0K | EDGAR |
| 2023-07-19 | BCYC | Grant (A) | — | $0 | EDGAR |
| 2023-02-23 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-09 | PTCT | Grant (A) | +4,000 | $0 | EDGAR |
| 2022-06-10 | PTCT | Grant (A) | +5,067 | $0 | EDGAR |
| 2022-04-05 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–27 of 27
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.